increas
concentr
solubl
hla
class
class
ii
molecul
shlai
shlaii
observ
infecti
inflammatori
autoimmun
diseas
autoimmun
mechan
consid
play
role
pathogenesi
multipl
sclerosi
ms
decid
dose
shlai
shlaii
serum
cerebrospin
fluid
csf
ms
patient
compar
concentr
observ
serum
csf
patient
neurolog
diseas
ond
without
evid
neuroradiolog
involv
central
nervou
system
cn
serum
healthi
donor
serum
concentr
shlai
higher
ms
ond
patient
healthi
donor
p
wherea
shlaii
serum
concentr
lower
ms
patient
ond
patient
healthi
donor
p
detect
amount
shlaii
observ
csf
ms
patient
csf
ond
patient
p
ms
patient
signific
correl
shlai
serum
csf
concentr
observ
p
wherea
shlaii
serum
csf
level
correl
conclus
alter
shlai
shlaii
serum
csf
concentr
present
ms
patient
could
involv
induct
enhanc
suscept
develop
ms
ms
pathogenesi
human
immunolog
solubl
hla
class
class
ii
molecul
shlai
shlaii
respect
circul
serum
healthi
subject
mechan
lead
presenc
shlai
shlaii
serum
complet
understood
possibl
shed
membran
damag
lyse
cell
secret
activ
immun
cell
fact
serum
level
shlai
shlaii
increas
acut
reject
episod
follow
organ
transplant
acut
graftversushost
diseas
follow
bone
marrow
transplant
well
phenomena
involv
immun
activ
like
infecti
autoimmun
diseas
furthermor
report
shlai
shlaii
may
play
immunomodulatori
role
mainli
downregul
activ
immun
cell
autoimmun
certainli
play
major
role
pathogenesi
multipl
sclerosi
ms
demyelin
diseas
central
nervou
system
cn
support
assess
come
genet
histolog
immunolog
observ
particular
evid
haplotyp
commonli
associ
ms
caucasian
subject
moreov
perivascular
cuf
around
cn
venul
infiltr
lymphocyt
plasmacel
mononuclear
cell
found
acut
ms
lesion
final
lymphocyt
autoantibodi
reactiv
myelin
basic
protein
mbp
myelin
protein
myelin
oligodendrocyt
glycoprotein
mog
proteolipid
protein
plp
myelin
associ
glycoprotein
mag
isol
blood
cerebrospin
fluid
csf
ms
patient
although
autoreact
mbpspecif
cell
autoantibodi
mbp
also
detect
blood
csf
normal
donor
thu
autoantigen
present
specif
hla
molecul
autoreact
lymphocyt
appear
key
factor
pathogenesi
diseas
therefor
abnorm
serum
concentr
shlai
shlaii
expect
ms
patient
moreov
detect
shlai
molecul
csf
demonstr
could
interest
investig
presenc
biolog
behavior
shlai
shlaii
molecul
csf
ms
patient
howev
best
present
knowledg
inform
exist
level
shlai
shlaii
serum
csf
ms
patient
aim
studi
quantit
concentr
shlai
shlaii
molecul
sera
csf
ms
patient
compar
level
observ
normal
control
subject
patient
affect
neurolog
diseas
ond
sera
csf
collect
ms
patient
frozen
util
patient
sex
age
clinic
featur
diseas
summar
tabl
ms
subject
definit
diagnosi
relapsingremit
ms
accord
criteria
poser
et
al
ms
patient
sera
csf
collect
within
day
onset
clinic
relaps
defin
appear
new
symptom
worsen
old
one
accompani
appropri
neurolog
abnorm
last
least
h
absenc
fever
preced
period
stabil
improv
least
day
ms
patient
assum
steroid
immunosuppress
drug
csf
analysi
show
increas
immunoglobulin
ig
g
index
case
presenc
oligoclon
band
isoelectrofocus
case
sera
csf
ond
patient
tabl
affect
diseas
epilepsi
headach
psychiatr
disord
without
clinic
laboratori
csf
examin
includ
igg
index
neuroradiolog
computer
tomographi
evid
organ
involv
cn
also
collect
frozen
specifi
sera
healthi
subject
use
control
monoclon
antibodi
moab
direct
nonpolymorph
determin
chain
hla
class
ii
antigen
moab
recogn
nonpolymorph
determin
hla
class
ii
antigen
moab
microglobulin
kind
gift
dr
ferron
new
york
medic
colleg
valhalla
ny
monoclon
antibodi
framework
determin
microglobulin
associ
hla
class
kind
gift
dr
c
russo
cornel
univers
new
york
ny
peroxidaseconjug
sheep
antimous
ig
antibodi
purchas
amersham
buckinghamshir
england
level
shlai
shlaii
serum
csf
determin
previous
describ
doubl
determin
immunoassay
ddia
minor
modif
use
biotinconjug
moab
biotinconjug
moab
respect
calcul
shlai
index
shlai
shlaii
present
csf
might
synthet
within
cn
could
come
blood
blood
brain
barrier
bbb
discrimin
two
possibl
calcul
shla
index
describ
calcul
ratio
concentr
shla
molecul
csf
serum
relat
variabl
csf
albumin
serum
albumin
ratio
reflect
bbb
statu
calcul
perform
shlai
csf
concentr
shlaii
ond
patient
detect
limit
assay
subject
shlai
index
hii
calcul
follow
formula
hii
csf
shlaiserum
shlai
csf
albuminserum
albumin
upper
normal
limit
hii
consid
mean
shla
index
ond
patient
plu
standard
deviat
valu
exceed
limit
consid
indic
intrathec
synthesi
shlai
molecul
statist
analysi
shlai
shlaii
concentr
express
gml
mean
sd
comparison
among
group
serum
concentr
shlai
significantli
increas
ms
gml
ond
gml
patient
respect
healthi
subject
gml
p
p
respect
fig
serum
shlai
level
compar
ms
patient
relaps
gml
ms
patient
stabl
clinic
cours
gml
fig
valu
significantli
higher
healthi
subject
p
serum
concentr
shlaii
ms
patient
gml
significantli
lower
ond
patient
gml
p
healthi
subject
gml
p
fig
statist
signific
differ
shlaii
serum
concentr
observ
ms
patient
relaps
gml
stabl
phase
diseas
gml
fig
serum
concentr
shlaii
ms
patient
subpopul
significantli
lower
ond
patient
healthi
subject
p
csf
concentr
shlai
molecul
compar
ms
gml
ond
patient
gml
fig
nevertheless
csf
concentr
shlai
significantli
increas
ms
patient
stabl
diseas
gml
respect
ms
patient
relaps
gml
p
fig
ond
patient
p
detect
concentr
gml
shlaii
molecul
found
csf
ms
patient
csf
ond
patient
gml
differ
percentag
frequenc
two
popul
statist
signific
p
fig
multipl
sclerosi
patient
relaps
show
higher
concentr
csf
shlaii
molecul
gml
ms
patient
stabl
diseas
gml
although
differ
statist
signific
p
hii
ond
ms
patient
gml
gml
respect
latter
valu
lower
upper
normal
limit
hii
gml
assum
shlai
present
csf
ms
patient
intrathec
produc
came
peripher
blood
statist
signific
correl
observ
ms
patient
serum
csf
shlai
concentr
p
fig
wherea
correl
detect
serum
csf
shlaii
concentr
fig
present
studi
compar
concentr
shlai
shlaii
serum
csf
ms
patient
serum
healthi
subject
serum
csf
ond
patient
main
result
obtain
follow
shlai
serum
concentr
significantli
higher
ms
patient
healthi
subject
compar
sera
csf
ms
ond
patient
b
shlaii
serum
concentr
significantli
lower
ms
patient
healthi
subject
ond
patient
wherea
detect
amount
shlaii
found
csf
ms
patient
csf
ond
patient
c
statist
signific
correl
observ
ms
patient
serum
csf
shlai
concentr
csf
shlai
concentr
significantli
lower
wherea
csf
shlaii
concentr
higher
although
significantli
ms
patient
relaps
ms
patient
stabl
diseas
autoimmun
phenomena
consid
play
major
role
pathogenesi
ms
lymphocyt
reactiv
antigen
present
cn
demonstr
blood
csf
ms
patient
recent
crossreact
mbp
specif
tcell
clone
structur
antigen
human
coronaviru
describ
thu
support
hypothesi
exogen
factor
ie
viral
antigen
genet
predispos
individu
might
induc
autoimmun
antigenmimick
particular
autoantigen
present
hla
restrict
phenomena
could
primarili
involv
predispos
genet
background
ms
develop
elev
rate
concord
ms
manifest
monozygot
twin
frequent
associ
ms
haplotyp
furtherli
underlin
pathogenet
role
hla
haplotyp
ms
moreov
known
high
low
serum
level
shlai
shlaii
may
associ
particular
hla
allospecif
base
variat
serum
shlai
shlaii
concentr
ms
patient
report
studi
could
acquir
pathogenet
relev
result
recent
studi
suggest
shlai
shlaii
molecul
may
exert
immunosuppress
activ
lymphocyt
function
respect
elev
shlai
decreas
shlaii
ms
sera
prospect
potenti
scenario
coexist
downmodul
tcell
function
increas
shlai
level
poorli
control
tcell
function
reduc
shlaii
concentr
could
predispos
occurr
chronic
viral
infect
longterm
antigen
releas
thu
favor
select
tcell
clone
crossreact
self
antigen
structur
altern
observ
alter
shla
molecul
homeostasi
could
epiphenomenon
underli
autoimmun
phenomena
view
increas
shlai
serum
level
might
mere
consequ
inflammatori
statu
might
due
either
shed
dead
cell
secret
activ
cell
howev
decreas
serum
shlaii
level
difficult
simpli
interpret
secondari
manifest
concord
increas
shlai
shlaii
concentr
detect
serum
infecti
inflammatori
diseas
studi
mean
elev
serum
shlai
level
ond
patient
difficult
explain
patient
neither
signific
laboratori
sign
peripher
cn
inflamm
observ
cn
lesion
detect
neuroradiolog
examin
ond
case
show
clinic
symptom
sign
involv
peripher
central
nervou
system
ie
facial
palsi
epilepsi
sciatica
may
hypothes
case
unspecif
activ
immun
system
could
occur
compar
concentr
shlai
molecul
found
csf
ms
ond
patient
exist
ms
patient
signific
correl
serum
csf
shlai
concentr
fact
hii
hii
upper
normal
limit
support
hypothesi
patient
shlai
concentr
found
csf
come
blood
bbb
interestingli
significantli
lower
shlai
concentr
detect
csf
ms
patient
relaps
stabl
diseas
thu
indic
intracn
variat
shlai
concentr
associ
differ
clinic
phase
diseas
shlaii
molecul
undetect
csf
major
ond
patient
wherea
detect
almost
half
ms
patient
mainli
ms
patient
flare
diseas
thu
presenc
shlaii
csf
ms
patient
appear
diseaserel
phenomenon
fact
highest
shlaii
concentr
found
csf
ms
patient
relaps
perhap
relat
releas
molecul
phenomena
phase
local
immun
activ
unfortun
limit
volum
csf
avail
patient
allow
purif
suffici
amount
shlaii
test
effect
activ
lymphocyt
ms
patient
correl
found
csf
serum
shlaii
level
like
csf
shlaii
molecul
produc
within
cn
could
shed
hla
class
ii
posit
cell
microglia
cell
die
cn
could
secret
activ
immun
cell
must
consid
simpl
clinic
observ
give
us
reliabl
inform
activ
diseas
magnet
reson
imag
mri
contrast
enhanc
gadolinium
often
show
activ
disord
disrupt
bbb
also
appar
stabl
clinic
phase
diseas
fact
serial
mri
gadolinium
almost
tenfold
sensit
clinic
examin
detect
ongo
diseas
activ
therefor
futur
effort
direct
correl
amount
serum
csf
shlai
shlaii
togeth
solubl
mediat
inflamm
mri
sign
diseas
activ
moment
therefor
possibl
affirm
whether
absenc
signific
amount
shlaii
csf
half
ms
patient
studi
relat
differ
phase
diseas
express
differ
form
ms
conclus
result
studi
show
exist
imbal
shlai
shlaii
concentr
serum
csf
ms
patient
whether
alter
may
play
pathogenet
role
whether
detect
could
diagnost
relev
ms
deserv
investig
